Flora Growth (FLGC) to Release Quarterly Earnings on Monday

Flora Growth (NASDAQ:FLGC) is expected to be issuing its Q4 2025 results before the market opens on Monday, March 23rd. Analysts expect the company to announce earnings of ($1.97) per share for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 27, 2026 at 7:00 AM ET.

Flora Growth Price Performance

Shares of NASDAQ:FLGC opened at $9.64 on Friday. The business’s 50-day moving average is $8.10 and its 200 day moving average is $11.63. Flora Growth has a 1 year low of $5.86 and a 1 year high of $47.00. The firm has a market capitalization of $10.08 million, a P/E ratio of -0.30 and a beta of 1.90.

Analyst Ratings Changes

Several brokerages have recently issued reports on FLGC. Weiss Ratings reissued a “sell (e+)” rating on shares of Flora Growth in a report on Thursday, January 22nd. Wall Street Zen raised Flora Growth from a “sell” rating to a “hold” rating in a report on Saturday, January 17th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $30.00.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Flora Growth stock. Geode Capital Management LLC increased its stake in shares of Flora Growth Corp. (NASDAQ:FLGC) by 1.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 168,572 shares of the company’s stock after buying an additional 3,015 shares during the quarter. Geode Capital Management LLC owned about 29.16% of Flora Growth worth $98,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 36.01% of the company’s stock.

About Flora Growth

Flora Growth Corp (NASDAQ: FLGC) is a vertically integrated cannabis and hemp company engaged in the cultivation, extraction, formulation and distribution of cannabinoid-based products. Its portfolio encompasses a broad range of offerings, including oils, vape cartridges, edibles, topicals and patent-pending delivery systems designed for both medical and wellness applications.

Founded in 2018, Flora Growth has established cultivation and processing operations in Uruguay’s greenhouse hubs, complemented by extraction and formulation laboratories in Florida.